英文别名：
Orphenadrine Related Compound E (50 mg) (N,N-Dimethyl-2-[phenyl(m-tolyl)methoxy]ethanamine);N,N-Dimethyl-2-[(3-methylphenyl)phenylmethoxy]ethanamine;N,N-Dimethyl-2-[phenyl(m-tolyl)methoxy]ethanamine;Ethanamine, N,N-dimethyl-2-((3-methylphenyl)phenylmethoxy)-;A40KR91PE2;Orphenadrine meta-methylbenzyl isomer;(RS)-N,N-Dimethyl-2-((3-methylphenyl)phenylmethoxy)ethanamine;N,N-dimethyl-N-{2-[(3-methylphenyl)(phenyl)methoxy]ethyl}amine;O-Demethyl-m-methyl orphenadrine;Orphenadrine impurity E;ETHYLAMINE, N,N-DIMETHYL-2-((M-METHYL-.ALPHA.-PHENYLBENZYL)OXY)-;Ethylamine, N,N-dimethyl-2-((m-methyl-alpha-phenylbenzyl)oxy)-;3-Methyldiphenhydramine;N,N-dimethyl-2-[(3-methylphenyl)-phenylmethoxy]ethanamine;AM-814/41091386;21945-86-8;UNII-A40KR91PE2;Orphenadrine citrate specified impurity E [EP];ORPHENADRINE CITRATE IMPURITY E [EP IMPURITY];Q27273594;Orphenadrine citrate impurity E [EP];WAA94586;Orphenadrine citrate specified impurity E;ORPHENADRINE CITRATE IMPURITY E (EP IMPURITY);Orphenadrine citrate impurity E;110-989-1;
Inchi：
1S/C18H23NO/c1-15-8-7-11-17(14-15)18(20-13-12-19(2)3)16-9-5-4-6-10-16/h4-11,14,18H,12-13H2,1-3H3
3001086693 
![5-bromo-1H-pyrrolo[3,2-b]pyridine-2-carboxylic acid](http://hg.y866.cn/compound/lib/scimg/cas/150/800401-52-9.png "5-bromo-1H-pyrrolo[3,2-b]pyridine-2-carboxylic acid")
![1-[3-(4-oxocyclohexa-2,5-dien-1-ylidene)-4H-pyrido[2,3-b]pyrazin-6-yl]-3-prop-2-enylthiourea](http://hg.y866.cn/compound/lib/scimg/cas/150/800394-83-6.png "1-[3-(4-oxocyclohexa-2,5-dien-1-ylidene)-4H-pyrido[2,3-b]pyrazin-6-yl]-3-prop-2-enylthiourea")
